alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
(logo)LNR

          Partners, LLC

 

 

ANNUAL STATEMENT OF COMPLIANCE

 

OF

 

LNR PARTNERS, LLC

 

 

The undersigned, Job Warshaw,being the President of LNR Partners, LLC (the “Special Servicer”), as specialservicer under the applicable Pooling and Servicing Agreement for thetransactions listed on Schedule I hereto, hereby certifies, subject toany limitations listed on Schedule I hereto, as of the date hereof, onbehalf of the Special Servicer, solely in his capacity as an authorized officerof the Special Servicer and not in his individual capacity, as follows:

 

1.            A review ofthe activities performed by the Special Servicer during the period commencingon January 1, 2019 and ending on December 31, 2019 (or any other shorter periodset forth on Schedule I hereto) (the “'Reporting Period”), and of theSpecial Servicer’s performance under the Pooling and Servicing Agreement hasbeen made under my supervision; and

 

2.            To the bestof my knowledge, based on such review and using the applicable servicingcriteria under Item 1122 of Regulation AB, the Special Servicer has fulfilledall of its obligations under the applicable Pooling and Servicing Agreement inall material respects throughout the Reporting Period.

 

LNR PARTNERS, LLC,

a Florida limited liabilitycompany

 

 

By: /s/ Job Warshaw

Job Warshaw

President

 

 

Dated: February 20, 2020

 

 

1601 Washington Avenue • Suite 700 • Miami Beach,Florida 33139-3164

Telephone: (305) 695-5600 • Fax: (305) 695-5601

 

 

 

**Schedule I**

 

 

MSBAM 2015-C24

Morgan Stanley Bank of AmericaMerrill Lynch Trust 2015-C24, Commercial Mortgage Pass-Through Certificates,Series 2015-C24

 

Morgan Stanley Capital I Inc.

1221 Avenue of the Americas

New York NY 10020

James Y. Lee

 

Morgan Stanley Capital I Inc.

1585 Broadway

New York NY 10036

Stephen Holmes

 

Park Bridge Lender ServicesLLC

600 Third Avenue, 40th Floor

Att: MSBAM 2015-C24

New York NY 10016

Group

 

Wells Fargo Bank, N.A.

9062 Old Annapolis Road

Columbia MD 21045

Group Notices

**Schedule I**

 

MSBAM 2015-C24

Morgan Stanley Bank of AmericaMerrill Lynch Trust 2015-C24, Commercial Mortgage Pass-Through Certificates,Series 2015-C24

(32 Old Slip Fee – under MSBAM2015-C23)

 

Morgan Stanley Capital I Inc.

1221 Avenue of the Americas

New York NY 10020

James Y. Lee

 

Morgan Stanley Capital I Inc.

1585 Broadway

New York NY 10036

Stephen Holmes

 

Park Bridge Lender ServicesLLC

600 Third Avenue, 40th Floor

Att: MSBAM 2015-C24

New York NY 10016

Group

 

Wells Fargo Bank, N.A.

9062 Old Annapolis Road

Columbia MD 21045

Group Notices
PFS CORPORATION 1 of 2 Created on: 2009-09-09 

F95-8-5-CBScopeListingTemplate-2009-4-14 

CERTIFICATION BODY ACCREDITATION PROGRAM 

Accredited Legal Entity: 

PFS CORPORATION

1507 Matt Pass, Cottage Grove, WI 53527 U.S.A. 

Telephone: (608) 839-1013 Fax: (608) 839-1014 

Email: jrothman@pfscorporation.com 

Any additional critical/key locations included in the scope of accreditation are appended to this listing. 

Accreditation Standards: 

CAN-P-3G (ISO/IEC Guide 65:1996) 

CAN-P-1500M 

IAF GD 5:2006 

Certification Mark: 

 

Product Certification System Type:

The product certification system operated by this organization most closely resembles that described by 

ISO/IEC Guide 67, Conformity assessment — Fundamentals of product certification, System 5. It includes 

the evaluation of samples requested by the certification body, determination of characteristics by testing or 

assessment, initial assessment of the production process or the quality system, as applicable, evaluation of 

the test and assessment reports, license, on-going surveillance by testing or inspection of samples from the 

factory or the open market, or both depending on the product type, as well as on-going surveillance of the 

production process or quality system or both. 

Subject Areas of Accreditation: 

The scope of accreditation for the above-mentioned legal entity limits the use of the certification mark 

shown, to products that meet standards classified by the following international classification coding: 
PFS CORPORATION 2 of 2 Created on: 2009-09-09 

F95-8-5-CBScopeListingTemplate-2009-4-14 

ICS No. Title Purpose 

13.220.40 Ignitability and burning behaviour of materials and products Safety & Performance 

13.220.50 Fire-resistance of building materials and elements Performance 

79.040 Wood, sawlogs and sawn timber Performance 

79.060.01 Wood–based panels in General Performance 

79.060.10 Plywood Performance 

79.060.20 Fibre and particle boards Performance 

79.080 Semi-manufactures of timber Performance 

83.080.20 Thermoplastic Materials Performance 

91.060.10 Walls. Partitions. Façades Performance 

91.060.20 Roofs Performance 

91.060.30 Ceilings. Floors. Stairs Performance 

91.080.20 Timber structures Performance 

91.100.99 Other construction materials (Construction adhesives for 

wood) 

Performance 

91.140.10 Central heating systems 

(Gas, oil and solid fuel-fired systems only) 

Performance and Safety 

97.040.20 Cooking ranges, working tables, ovens and similar 

appliances 

Performance and Gas 

Safety 

97.100.20 Gas heaters Performance 

Gas Safety 

Energy Efficiency 

97.100.30 Solid fuel heaters Performance and Safety 

97.100.40 Liquid fuel heaters Performance and Safety 

97.180 Miscellaneous domestic and commercial equipment 

(Campsite fire logs, starts, and 

gas-fired log lighters) 

Performance and Safety 

Other Critical/Key Locations

The certification activities conducted by the above-mentioned legal entity at the following locations are also 

included in this scope of accreditation: 

Country Address Location 

United States PFS Corporation 

3637 Motor Ave., Suite 380 

Los Angeles, CA 90034 

Los Angeles
```

[Federal Register Volume 79, Number 152 (Thursday, August 7, 2014)]
[Notices]
[Page 46296]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-18698]

-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice 8817]

Culturally Significant Objects Imported for Exhibition 
Determinations: ``Sculpture Victorious: Art in an Age of Invention, 
1837-1901''

SUMMARY: Notice is hereby given of the following determinations: 
Pursuant to the authority vested in me by the Act of October 19, 1965 
(79 Stat. 985; 22 U.S.C. 2459), Executive Order 12047 of March 27, 
1978, the Foreign Affairs Reform and Restructuring Act of 1998 (112 
Stat. 2681, et seq.; 22 U.S.C. 6501 note, et seq.), Delegation of 
Authority No. 234 of October 1, 1999, and Delegation of Authority No. 
236-3 of August 28, 2000 (and, as appropriate, Delegation of Authority 
No. 257 of April 15, 2003), I hereby determine that the objects to be 
included in the exhibition ``Sculpture Victorious: Art in an Age of 
Invention, 1837-1901,'' imported from abroad for temporary exhibition 
within the United States, are of cultural significance. The objects are 
imported pursuant to loan agreements with the foreign owners or 
custodians. I also determine that the exhibition or display of the 
exhibit objects at the Yale Center for British Art, New Haven, 
Connecticut, from on or about September 11, 2014, until on or about 
November 30, 2014, and at possible additional exhibitions or venues yet 
to be determined, is in the national interest. I have ordered that 
Public Notice of these Determinations be published in the Federal 
Register.

FOR FURTHER INFORMATION CONTACT: For further information, including a 
list of the imported objects, contact Paul W. Manning, Attorney-
Adviser, Office of the Legal Adviser, U.S. Department of State 
(telephone: 202-632-6469). The mailing address is U.S. Department of 
State, SA-5, L/PD, Fifth Floor (Suite 5H03), Washington, DC 20522-0505.

    Dated: July 31, 2014.
Kelly Keiderling,
Principal Deputy Assistant Secretary, Bureau of Educational and 
Cultural Affairs, Department of State.
[FR Doc. 2014-18698 Filed 8-6-14; 8:45 am]
BILLING CODE 4710-05-P
```
#### § 801.116 Medical devices having commonly known directions.

A device shall be exempt from section 502(f)(1) of the act insofar as adequate directions for common uses thereof are known to the ordinary individual.
§ 556.277 Fenprostalene. ( a ) *Acceptable daily intake (ADI).* The ADI for total residue of fenprostalene is 0.08 μg/kg of body weight per day.
( b ) *Tolerances.* The tolerances for fenprostalene are: ( 1 ) *Cattle.* Edible tissues (excluding milk): Not required.
( 2 ) *Swine.* Edible tissues: Not required.
( c ) *Related conditions of use.* See § 522.914 of this chapter.
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.3127 Vinyl alcohol/methyl methacrylate-dye reaction products. ( a ) *Identity.* The color additives are formed by reacting the dyes, either alone or in combination, with a vinyl alcohol/methyl methacrylate copolymer, so that the sulfate groups of the dyes are replaced by ether linkages to the vinyl alcohol/methyl methacrylate copolymer. The dyes are: ( 1 ) C.I. Reactive Red 180 [5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthalenyl)azo)-2,7-naphthalenedisulfonic acid, tetrasodium salt] (CAS Reg. No. 98114-32-0).
( 2 ) C.I. Reactive Black 5 [2,7-naphthalenedisulfonic acid, 4-amino-5-hydroxy-3,6-bis((4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-, tetrasodium salt] (CAS Reg. No. 17095-24-8).
( 3 ) C.I. Reactive Orange 78 [2-naphthalenesulfonic acid, 7-(acetylamino)-4-hydroxy-3-((4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-] (CAS Reg. No. 68189-39-9).
( 4 ) C.I. Reactive Yellow 15 [benzenesulfonic acid, 4-(4,5-dihydro-4-((2-methoxy-5-methyl-4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-3-methyl-5-oxo-1*H*-pyrazol-1-yl)-] (CAS Reg. No. 60958-41-0).
( 5 ) C.I. Reactive Blue No. 19 [2-anthracenesulfonic acid, 1-amino-9,10-dihydro-9,10-dioxo-4-((3-((2-(sulfooxy)ethyl)sulfonyl)phenyl)amino)-, disodium salt] (CAS Reg. No. 2580-78-1).
( 6 ) C.I. Reactive Blue 21 [copper, (29*H*,31*H*-phthalocyaninato(2-)-*N* 29, *N* 30, *N* 31, *N* 32)-, sulfo((4-((2-(sulfooxy) ethyl)sulfonyl)phenyl)amino)sulfonyl derivatives] (CAS Reg. No. 73049-92-0).
( b ) *Uses and restrictions.* ( 1 ) The substances listed in paragraph (a) of this section may be used to color contact lenses in amounts not to exceed the minimum reasonably required to accomplish the intended coloring effect.
( 2 ) As part of the manufacturing process, the lenses containing the color additives are thoroughly washed to remove unbound reactive dye.
( 3 ) Authorization and compliance with this use shall not be construed as waiving any of the requirements of sections 510(k), 515, and 520(g) of the Federal Food, Drug, and Cosmetic Act (the act). A person intending to introduce a device containing a vinyl alcohol/methyl methacrylate-dye reaction product listed under this section into commerce shall submit to the Food and Drug Administration either a premarket notification in accordance with subpart E of part 807 of this chapter, if the device is not subject to premarket approval, or submit and receive approval of an original or supplemental premarket approval application if the device is subject to premarket approval.
( c ) *Labeling.* The label of the color additive shall conform to the requirements of § 70.25 of this chapter.
( d ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health, and therefore, this color additive is exempt from the certification requirements of section 721(c) of the act.
[58 FR 3227, Jan. 8, 1993, as amended at 58 FR 17510, Apr. 5, 1993]
# C_2014315EN.01002501.xml

| 15.9.2014 | EN | Official Journal of the European Union | C 315/25 |
| --- | --- | --- | --- |

15.9.2014

EN

Official Journal of the European Union

C 315/25

---

Request for an opinion submitted by the Republic of Malta pursuant to Article 218(11) TFEU

(Opinion 1/14)

2014/C 315/37

Language of the case: all the official languages

Applicant

Applicant

Republic of Malta (represented by: A. Buhagiar, P. Grech, Agents)

Question submitted to the Court

Question submitted to the Court

Is the Council of Europe Draft Convention against the Manipulation of Sports Competitions, insofar as it regulates sports betting and defines ‘illegal sports betting’ in Article 3(5)(a) as ‘all sports betting activity whose type or operator is not allowed under the applicable law of the jurisdiction where the consumer is located’, in conjunction with Articles 9 and 11 thereof which target ‘illegal sports betting’ so defined, compatible with the Treaties, particularly Articles 18, 49 and 56 TFEU?

---
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM(A)
A FORM 10-QSB FOR THE QUARTER ENDED MARCH 31, 1999 AND IS QUALIFIED IN ITS 
ENTIRETY BY REFERENCE TO SUCH (B) FORM 10-QSB
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                         835,483
<SECURITIES>                                   165,221
<RECEIVABLES>                                1,053,200
<ALLOWANCES>                                         0
<INVENTORY>                                    796,517
<CURRENT-ASSETS>                             2,939,051
<PP&E>                                       5,930,233
<DEPRECIATION>                               1,761,295
<TOTAL-ASSETS>                               7,116,739
<CURRENT-LIABILITIES>                          790,133
<BONDS>                                      1,307,721
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     1,426,916
<OTHER-SE>                                   3,420,009
<TOTAL-LIABILITY-AND-EQUITY>                 7,116,739
<SALES>                                      1,853,327
<TOTAL-REVENUES>                             1,861,441
<CGS>                                          884,663
<TOTAL-COSTS>                                  609,598
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              25,840
<INCOME-PRETAX>                                341,340
<INCOME-TAX>                                   132,184
<INCOME-CONTINUING>                            209,156
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   209,156
<EPS-PRIMARY>                                      .06
<EPS-DILUTED>                                      .06
        

</TABLE>
<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                      DEC-30-2000
<PERIOD-START>                         JAN-02-2000
<PERIOD-END>                           SEP-30-2000
<CASH>                                       13100
<SECURITIES>                                     0
<RECEIVABLES>                                48300
<ALLOWANCES>                                  2200
<INVENTORY>                                 442400
<CURRENT-ASSETS>                            531400
<PP&E>                                      391600
<DEPRECIATION>                              136200
<TOTAL-ASSETS>                              838400
<CURRENT-LIABILITIES>                       414900
<BONDS>                                          0
<PREFERRED-MANDATORY>                            0
<PREFERRED>                                      0
<COMMON>                                       300
<OTHER-SE>                                  296200
<TOTAL-LIABILITY-AND-EQUITY>                838400
<SALES>                                    1621800
<TOTAL-REVENUES>                           1621800
<CGS>                                      1108900
<TOTAL-COSTS>                              1108900
<OTHER-EXPENSES>                            397700
<LOSS-PROVISION>                                 0
<INTEREST-EXPENSE>                            6100
<INCOME-PRETAX>                             109100
<INCOME-TAX>                                 42800
<INCOME-CONTINUING>                          42800
<DISCONTINUED>                                   0
<EXTRAORDINARY>                                  0
<CHANGES>                                        0
<NET-INCOME>                                 42800
<EPS-BASIC>                                   2.15
<EPS-DILUTED>                                 2.11



</TABLE>
# D^7--^5-r
- /???
- 393S ^ Devany , Denni s (OST) From : . Jef f leagu e [tcot@ipa.net ] Sent : Monday , Ma y24 , 201 0 2:4 8 P M To : Devany , Denni s (OST ) Subject : SeaPort Airline servic e chang e reques t Dennis : Th e cit yof E l Dorad o enthusiasticall ysupport s SeaPort' s propose d chang e i n fligh t schedul e pe ra lette rt o yo u date d Ma y 21 , 2010
. I f yo u nee d a forma l lette rstatin g suc h w e woul d b e happ yt o provid e it
. Also , ca n yo u provid e an yupdat e a s t o th e statu s ofth e SCASD P applicatio n o n file ? Thanks
. Jeff Teague , Chairma n E l Dorad o Airport Commissio n
EXHIBIT 31.1

CERTIFICATION

SECTION 302 CERTIFICATION OF OUR CHIEF EXECUTIVE OFFICER

I, Perry Law, certify that:



1.    I have reviewed this annual report on Form 10-KSB of Smart-tek Solutions, Inc.;



2.

Based on my knowledge, this report does not contain any untrue statement of

material fact or omit to state a material fact necessary to make the statements

made, in light of the circumstances under which such statements were made,

not misleading with respect to the period covered by this report;



3.    Based on my knowledge, the financial statements, and other financial

information included in this report, fairly present in all material

respects the financial condition, results of operations and cash flows of

the registrant as of, and for, the periods presented in this report;



4.    The registrant's other certifying officer and I are responsible for

establishing and maintaining disclosure controls and procedures (as

defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant

and have:



(a)   Designed such disclosure controls and procedures, or caused such

disclosure controls and procedures to be designed under our

supervision, to ensure that material information relating to the

registrant, including its consolidated subsidiaries, is made known

to us by others within those entities, particularly during the

period in which this report is being prepared;



(b)   Evaluated the effectiveness of the registrant's disclosure controls

and procedures and presented in this report our conclusions about

the effectiveness of the disclosure controls and procedures, as of

the end of the period covered by this report based on such

evaluation; and



(c)   Disclosed in this report any change in the registrant's internal

control over financial reporting that occurred during the

registrant's most recent fiscal quarter (the registrant's fourth

quarter in the case of an annual report) that has materially

affected, or is reasonably likely to materially affect, the

registrant's internal control over financial reporting; and



5.    The registrant's other certifying officer and I have disclosed, based on

our most recent evaluation of internal control over financial reporting,

to the registrant's auditors and the audit committee of the registrant's

board of directors (or persons performing the equivalent functions):



(a)   All significant deficiencies and material weaknesses in the design

or operation of internal control over financial reporting which are

reasonably likely to adversely affect the registrant's ability to

record, process, summarize and report financial information; and



(b)   Any fraud, whether or not material, that involves management or

other employees who have a significant role in the registrant's

internal control over financial reporting.



/s/ Perry Law

---------------------------

Perry Law

Chief Executive Officer



October 11, 2006
§ 876.4480 Electrohydraulic lithotriptor. ( a ) *Identification.* An electrohydraulic lithotriptor is an AC-powered device used to fragment urinary bladder stones. It consists of a high voltage source connected by a cable to a bipolar electrode that is introduced into the urinary bladder through a cystoscope. The electrode is held against the stone in a water-filled bladder and repeated electrical discharges between the two poles of the electrode cause electrohydraulic shock waves which disintegrate the stone.
( b ) *Classification.* Class II. The special control for this device is FDA's “Guidance for the Content of Premarket Notifications for Intracorporeal Lithotripters.”
[48 FR 53023, Nov. 23, 1983, as amended at 52 FR 17738, May 11, 1987; 65 FR 17145, Mar. 31, 2000]
EDSUNITEDSTATESENVIRONMENTALPROTECTiONAGENCYREGIONIX75hawthorneStreetSanFrancisco,CA94105February24,2012SteveluffRioBravoJasmin19100VonKarman,Suite570Irvine,CA92612Re:CompletenessDeterminationforCleanAirAct(CAA)PreventionofSignificantDeterioration(PSD)PermitModificationforRioBravoJasmin(Jasmin)DearMr.luff:ThisletterconcernstheapplicationcompletenessstatusofRioBravoJasmin’sapplicationforamodificationtoPSDPermit#SJ85-07issuedtoRioBravoRefiningCompany(RioBravo)OflAugust19,1986.TheapplicationrequeststhatJasminbepermittedtoburncleancellulosicbiomassinadditiontothecurrentlypermittedfuelsofnaturalgas,coal,petroleumcokeandtirederivedfuel.ThefirstPSDapplicationmaterialsweredatedandreceivedbythisofficeonMay17,2010.ThesematerialsandsupplementalinformationprovidedbyRioBravowerenecessaryfor85-07onDecember13,2010andAugust29,2011.Additionalinformationrelatingtothismodificationwassubmittedonnumerousoccasions.Pursuantto40CFR124.3,EPAdeterminedtheapplicationtobecompleteonFebruary24,2012.Ifyoushouldhaveanyquestionsconcerningthismatter,pleasecontactOrnerShalevat(415)972-3538.Sincerely,M.GerardoC.’ios,Chief,PermitsOmcecc:Dr.TedGuthMaynardAdams,RioBravoJasminBillRossiter,RioBravoJasmin
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     Healthcare Properties, L.P. Financial Data Schedule
</LEGEND>
<CIK>                         0000814458
<NAME>                        Healthcare Properties, L.P.
<MULTIPLIER>                  1
<CURRENCY>                    U.S. Dollars

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>               DEC-31-1999
<PERIOD-START>                  JAN-01-1999
<PERIOD-END>                    SEP-30-1999
<EXCHANGE-RATE>                 1
<CASH>                          15,413,271
<SECURITIES>                    0
<RECEIVABLES>                   1,942,391
<ALLOWANCES>                    (792,395)
<INVENTORY>                     0
<CURRENT-ASSETS>                0
<PP&E>                          30,651,383
<DEPRECIATION>                  (13,967,924)
<TOTAL-ASSETS>                  33,493,513
<CURRENT-LIABILITIES>           0
<BONDS>                         0
<PREFERRED-MANDATORY>           0
<PREFERRED>                     0
<COMMON>                        0
<OTHER-SE>                      27,548,427
<TOTAL-LIABILITY-AND-EQUITY>    33,493,513
<SALES>                         0
<TOTAL-REVENUES>                8,291,580
<CGS>                           0
<TOTAL-COSTS>                   5,642,598
<OTHER-EXPENSES>                78,851
<LOSS-PROVISION>                0
<INTEREST-EXPENSE>              443,322
<INCOME-PRETAX>                 2,126,809
<INCOME-TAX>                    0
<INCOME-CONTINUING>             0
<DISCONTINUED>                  0
<EXTRAORDINARY>                 0
<CHANGES>                       0
<NET-INCOME>                    2,126,809
<EPS-BASIC>                   0
<EPS-DILUTED>                   0



</TABLE>